EUVIMEDEUVIMED entdecken
Crossref

Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations

Abdullahi Ibrahim Uba, Nicholas Joseph Paradis, Chun Wu, Gokhan Zengin

Amino Acids · 2023

DOI: 10.1007/s00726-023-03310-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Amino Acids, 2023. Verfasst von Abdullahi Ibrahim Uba und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Istanbul AREL University, 34537, Istanbul, Turkey. Hauptthemen laut MEDLINE: Adenosine Deaminase Inhibitors, Pentostatin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine deaminase (ADA) is a Zn2+-containing enzyme that catalyzes the irreversible deamination of adenosine to inosine or deoxyadenosine to deoxyinosine. In addition to this enzymatic function, ADA mediates cell-to-cell interactions involved in lymphocyte co-stimulation or endothelial activation. ADA is implicated in cardiovascular pathologies such as atherosclerosis and certain types of cancers, including lymphoma and leukemia. To date, only two drugs (pentostatin and cladribine) have been approved for the treatment of hairy cell leukemia. In search of natural ADA inhibitors, we demonstrated the binding of selected phenolic compounds to the active site of ADA using molecular docking and molecular dynamics simulation. Our results show that phenolic compounds (chlorogenic acid, quercetin, and hyperoside) stabilized the ADA complex by forming persistent interactions with the catalytically essential Zn2+ ion. Furthermore, MM-GBSA ligand binding affinity calculations revealed that hyperoside had a comparable binding energy score (ΔG = - 46.56 ± 8.26 kcal/mol) to that of the cocrystal ligand in the ADA crystal structure (PDB ID: 1O5R) (ΔG = - 51.97 ± 4.70 kcal/mol). Similarly, chlorogenic acid exhibited a binding energy score (ΔG = - 18.76 ± 4.60 kcal/mol) comparable to those of the two approved ADA inhibitor drugs pentostatin (ΔG = - 14.54 ± 2.25 kcal/mol) and cladribine (ΔG = - 25.52 ± 4.10 kcal/mol) while quercetin was found to have modest binding affinity (ΔG = - 8.85 ± 7.32 kcal/mol). This study provides insights into the possible inhibitory potential of these phenolic compounds against ADA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine Deaminase InhibitorsPentostatinMolecular Docking SimulationQuercetinCladribineLigandsChlorogenic AcidMolecular Dynamics Simulation

Stichwörter der Autor:innen

ADA inhibitorsAdenosine deaminase (ADA)MM-GBSAMolecular dockingMolecular dynamics simulationPhenolic compounds

Substanzen

Adenosine Deaminase InhibitorsPentostatinQuercetinCladribineLigandsChlorogenic Acid

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Istanbul AREL University, 34537, Istanbul, Turkey.
  • College of Science and Mathematics, Rowan University, Glassboro, NJ, 08028, USA.
  • College of Science and Mathematics, Rowan University, Glassboro, NJ, 08028, USA. wuc@rowan.edu.
  • Department of Biology, Science Faculty, Selcuk University, 42300, Konya, Turkey. gokhanzengin@selcuk.edu.tr.

Zitieren

APA

Uba, A. I., Paradis, N. J., Wu, C., & Zengin, G. (2023). Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations. Amino Acids. https://doi.org/10.1007/s00726-023-03310-4

Vancouver

Uba AI, Paradis NJ, Wu C, Zengin G. Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations. Amino Acids. 2023. doi:10.1007/s00726-023-03310-4

BibTeX
@article{Uba2023,
  author = {Uba, Abdullahi Ibrahim and Paradis, Nicholas Joseph and Wu, Chun and Zengin, Gokhan},
  title = {Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations},
  journal = {Amino Acids},
  year = {2023},
  doi = {10.1007/s00726-023-03310-4}
}
Kostenlos starten →